Previous Close | 2.5600 |
Open | 2.6100 |
Bid | 2.5000 x 1300 |
Ask | 2.7000 x 800 |
Day's Range | 2.5801 - 2.8700 |
52 Week Range | 1.1100 - 3.5300 |
Volume | |
Avg. Volume | 352,980 |
Market Cap | 180.301M |
Beta (5Y Monthly) | 2.18 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.6300 |
Earnings Date | Mar 27, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 7.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for GLYC
ROCKVILLE, Md., March 13, 2024--GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report fourth quarter and 2023 full year financial results on Wednesday, March 27, 2024 at 8:30 a.m. ET.
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
ROCKVILLE, Md., February 26, 2024--GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that Harout Semerjian, Chief Executive Officer, will participate in the Leukemia Panel at the Cowen 44th Annual Health Care Conference in Boston, MA on Monday, March 4, 2024 at 12:50 p.m. ET.